• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)中吸气峰值流速未达最佳水平的患病率及相关因素

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.

作者信息

Ghosh Sohini, Pleasants Roy A, Ohar Jill A, Donohue James F, Drummond M Bradley

机构信息

Division of Pulmonary Diseases and Critical Medicine, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA,

Durham VA Medical Center, Durham, NC, USA.

出版信息

Int J Chron Obstruct Pulmon Dis. 2019 Mar 1;14:585-595. doi: 10.2147/COPD.S195438. eCollection 2019.

DOI:10.2147/COPD.S195438
PMID:30880948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6402615/
Abstract

PURPOSE

Adequate peak inspiratory flow rate (PIFR) is required for drug dispersion with dry powder inhalers (DPIs). Prevalence of PIFR discordance (suboptimal PIFR with prescribed inhalers) and factors influencing device-specific PIFR are unclear in COPD. The objective of this study was to determine the prevalence of PIFR discordance and associated clinical factors in a stable COPD population.

PATIENTS AND METHODS

An observational, single-center, cohort study was conducted including 66 outpatients with COPD. PIFR was measured using the In-Check™ Dial with applied resistance of prescribed inhalers. Participants were defined as discordant if measured PIFR was <30 L/min and <60 L/min for high and low-medium resistance devices, respectively, using an inspiratory effort the participant normally used with their prescribed DPI.

RESULTS

The median age of the COPD participants was 69.4 years, 92% were white and 47% were female. A total of 48% were using low-medium resistance DPIs (Diskus/Ellipta) and 76% used high-resistance DPI (Handihaler). A total of 40% of COPD participants were discordant to prescribed inhalers. Female gender was the only factor consistently associated with lower PIFR. Shorter height was associated with reduced PIFR for low-medium resistance (=0.44; =0.01), but not high resistance (=0.20; =0.16). There was no correlation between PIFR by In-Check™ dial and PIFR measured by standard spirometer.

CONCLUSION

PIFR is reduced in stable COPD patients, with female gender being the only factor consistently associated with reduced PIFR. Discordance with prescribed inhalers was seen in 40% of COPD patients, suggesting that many COPD patients do not generate adequate inspiratory force to overcome prescribed DPIs resistance in the course of normal use.

摘要

目的

使用干粉吸入器(DPI)进行药物分散需要足够的吸气峰流速(PIFR)。慢性阻塞性肺疾病(COPD)患者中PIFR不一致(使用规定吸入器时PIFR未达最佳)的发生率以及影响特定装置PIFR的因素尚不清楚。本研究的目的是确定稳定期COPD患者中PIFR不一致的发生率及相关临床因素。

患者与方法

开展了一项观察性、单中心队列研究,纳入66例COPD门诊患者。使用In-Check™ Dial测量PIFR,并应用规定吸入器的阻力。如果参与者使用其规定DPI时正常吸气努力下,对于高阻力和低-中阻力装置,测量的PIFR分别<30 L/分钟和<60 L/分钟,则定义为不一致。

结果

COPD参与者的中位年龄为69.4岁,92%为白人,47%为女性。共有48%的患者使用低-中阻力DPI(Diskus/Ellipta),76%的患者使用高阻力DPI(Handihaler)。共有40%的COPD参与者与规定吸入器不一致。女性是唯一始终与较低PIFR相关的因素。身高较矮与低-中阻力装置的PIFR降低相关(=0.44;=0.01),但与高阻力装置无关(=0.20;=0.16)。In-Check™ Dial测量的PIFR与标准肺量计测量的PIFR之间无相关性。

结论

稳定期COPD患者的PIFR降低,女性是唯一始终与PIFR降低相关的因素。40%的COPD患者存在与规定吸入器不一致的情况,这表明许多COPD患者在正常使用过程中无法产生足够的吸气力来克服规定DPI的阻力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d4/6402615/9ee204d8f386/copd-14-585Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d4/6402615/dbf0ad36f639/copd-14-585Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d4/6402615/c7f2b3e78ea3/copd-14-585Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d4/6402615/9ee204d8f386/copd-14-585Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d4/6402615/dbf0ad36f639/copd-14-585Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d4/6402615/c7f2b3e78ea3/copd-14-585Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d4/6402615/9ee204d8f386/copd-14-585Fig3.jpg

相似文献

1
Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.慢性阻塞性肺疾病(COPD)中吸气峰值流速未达最佳水平的患病率及相关因素
Int J Chron Obstruct Pulmon Dis. 2019 Mar 1;14:585-595. doi: 10.2147/COPD.S195438. eCollection 2019.
2
Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.COPD 患者中未达最佳吸气峰流速的流行率及预测因素。
Eur J Pharm Sci. 2020 Apr 30;147:105298. doi: 10.1016/j.ejps.2020.105298. Epub 2020 Mar 6.
3
Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea.韩国慢性阻塞性肺疾病患者干粉吸入器使用中吸气峰流速不理想。
Pulm Pharmacol Ther. 2024 Jun;85:102298. doi: 10.1016/j.pupt.2024.102298. Epub 2024 Apr 10.
4
Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.使用观察到的肺功能结果预测峰值吸气流量的生理指标(POROS):慢性阻塞性肺疾病急性加重住院患者出院时的评估
Int J Chron Obstruct Pulmon Dis. 2018 Dec 13;13:3937-3946. doi: 10.2147/COPD.S174371. eCollection 2018.
5
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.哮喘和慢性阻塞性肺疾病的疾病严重程度对通过ELLIPTA®干粉吸入器的特定吸入器吸入特征的影响。
J Aerosol Med Pulm Drug Deliv. 2015 Dec;28(6):486-97. doi: 10.1089/jamp.2015.1224. Epub 2015 Sep 15.
6
Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler.在使用 Diskus®干粉吸入器模拟阻力时,吸气峰流速不佳的流行率和 COPD 表型。
J Aerosol Med Pulm Drug Deliv. 2013 Jun;26(3):174-9. doi: 10.1089/jamp.2012.0987. Epub 2012 Oct 1.
7
Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.比较布地奈德福莫特罗粉吸入剂(Breezhaler®)、噻托溴铵粉吸入剂(Ellipta®)和都保(HandiHaler®)干粉吸入器在中重度至极重度 COPD 患者中的吸气峰流速:一项随机交叉试验。
BMC Pulm Med. 2018 Jun 14;18(1):100. doi: 10.1186/s12890-018-0662-0.
8
Determinants of Suboptimal Peak Inspiratory Flow Rates among Patients with Chronic Obstructive Pulmonary Disease in Southwest, Nigeria.尼日利亚西南部慢性阻塞性肺疾病患者未达最佳吸气峰流速的决定因素。
West Afr J Med. 2023 May 27;40(5):553-561.
9
Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.慢性阻塞性肺疾病的最大吸气流量:对干粉吸入器的影响。
J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):381-387. doi: 10.1089/jamp.2017.1416. Epub 2017 Sep 21.
10
Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.慢性阻塞性肺疾病(COPD)患者中,吸气峰流速未达最佳状态时,干粉吸入与雾化吸入β受体激动剂的比较。
J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):103-9. doi: 10.1089/jamp.2013.1038. Epub 2013 Jun 8.

引用本文的文献

1
Evaluation of Preliminary Bronchodilation Effect on Aerosol Delivery from a Dry Powder Inhaler for Patients with Chronic Obstructive Pulmonary Disease with Suboptimal Peak Inspiratory Flow Rate.对吸气峰流速未达最佳的慢性阻塞性肺疾病患者,评估干粉吸入器气溶胶递送的初步支气管扩张效果。
Clin Pharmacokinet. 2025 Aug 29. doi: 10.1007/s40262-025-01560-x.
2
Development of a Scoring System to Predict Suboptimal Peak Inspiratory Flow in Patients With Chronic Obstructive Pulmonary Disease.一种用于预测慢性阻塞性肺疾病患者吸气峰流速未达最佳水平的评分系统的开发。
J Korean Med Sci. 2025 Jul 14;40(27):e139. doi: 10.3346/jkms.2025.40.e139.
3

本文引用的文献

1
Guiding Inspiratory Flow: Development of the In-Check DIAL G16, a Tool for Improving Inhaler Technique.引导吸气气流:In-Check DIAL G16的研发,一种改善吸入器技术的工具。
Pulm Med. 2017;2017:1495867. doi: 10.1155/2017/1495867. Epub 2017 Nov 16.
2
Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.慢性阻塞性肺疾病的最大吸气流量:对干粉吸入器的影响。
J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):381-387. doi: 10.1089/jamp.2017.1416. Epub 2017 Sep 21.
3
Prevalence of Low Peak Inspiratory Flow Rate at Discharge in Patients Hospitalized for COPD Exacerbation.
Maximal Forced Inspiratory Flow Dynamics and Acute Exacerbation in Chronic Obstructive Pulmonary Disease Patients with Exacerbation History.
有加重病史的慢性阻塞性肺疾病患者的最大用力吸气流量动力学与急性加重
Tuberc Respir Dis (Seoul). 2025 Jul;88(3):535-544. doi: 10.4046/trd.2024.0156. Epub 2025 Mar 28.
4
A 7-point evidence-based care discharge protocol for patients hospitalized for exacerbation of COPD: consensus strategy and expert recommendation.慢性阻塞性肺疾病急性加重住院患者基于证据的7点出院护理方案:共识策略与专家建议
NPJ Prim Care Respir Med. 2024 Dec 20;34(1):44. doi: 10.1038/s41533-024-00378-7.
5
Recalibrating Perceptions and Attitudes Toward Nebulizers versus Inhalers for Maintenance Therapy in COPD: Past as Prologue.重新校准慢性阻塞性肺疾病维持治疗中雾化器与吸入器的认知和态度:以史为鉴。
Int J Chron Obstruct Pulmon Dis. 2024 Nov 28;19:2571-2586. doi: 10.2147/COPD.S491275. eCollection 2024.
6
Suboptimal Peak Inspiratory Flow in Patients Hospitalized for COPD Exacerbation: Prevalence and Predictive Factors.慢性阻塞性肺疾病加重住院患者的吸气峰流速不佳:患病率及预测因素。
J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):225-231. doi: 10.1089/jamp.2024.0002. Epub 2024 Jun 19.
7
Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program: A Real-World Observational Study.专业慢性阻塞性肺疾病临床项目中的吸气峰流量与吸入器处方策略:一项真实世界观察性研究
Chest. 2025 Mar;167(3):736-745. doi: 10.1016/j.chest.2024.09.031. Epub 2024 Oct 9.
8
Comparisons between In-Check DIAL® and PF810® in evaluation and training inspiratory capacity for using dry powder inhalers.在评估和训练干粉吸入器吸气容量时,In-Check DIAL® 与 PF810® 的比较。
BMC Pulm Med. 2024 Aug 2;24(1):380. doi: 10.1186/s12890-024-03191-7.
9
Prevalence and Factors Affecting the Optimal and Non-optimal Peak Inspiratory Flow Rate in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease and Bronchial Asthma in India.印度慢性阻塞性肺疾病和支气管哮喘稳定期与加重期最佳和非最佳吸气峰流速的患病率及影响因素
Cureus. 2024 Apr 21;16(4):e58670. doi: 10.7759/cureus.58670. eCollection 2024 Apr.
10
Inappropriate Peak Inspiratory Flow Rate in the Patients with Stable Chronic Obstructive Pulmonary Disease in Korea.韩国稳定期慢性阻塞性肺疾病患者吸气峰流速不当的情况
Tuberc Respir Dis (Seoul). 2024 Oct;87(4):458-464. doi: 10.4046/trd.2023.0195. Epub 2024 Apr 25.
慢性阻塞性肺疾病急性加重住院患者出院时低吸气峰流速的患病率
Chronic Obstr Pulm Dis. 2017 Jul 15;4(3):217-224. doi: 10.15326/jcopdf.4.3.2017.0183.
4
Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease.峰吸气流率作为慢性阻塞性肺疾病干粉吸入器使用的标准。
Ann Am Thorac Soc. 2017 Jul;14(7):1103-1107. doi: 10.1513/AnnalsATS.201702-156PS.
5
Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions.吸气流量不足与慢性阻塞性肺疾病和全因再入院相关。
Ann Am Thorac Soc. 2017 Aug;14(8):1305-1311. doi: 10.1513/AnnalsATS.201611-903OC.
6
Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases.使用In-Check DIAL对患有阻塞性气道疾病的老年人的不同吸入器装置进行吸气峰流速测量。
J Asthma Allergy. 2017 Feb 23;10:17-21. doi: 10.2147/JAA.S127580. eCollection 2017.
7
Inhalation device requirements for patients' inhalation maneuvers.患者吸入动作对吸入装置的要求。
Respir Med. 2016 Sep;118:65-75. doi: 10.1016/j.rmed.2016.07.013. Epub 2016 Jul 21.
8
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.哮喘和慢性阻塞性肺疾病的疾病严重程度对通过ELLIPTA®干粉吸入器的特定吸入器吸入特征的影响。
J Aerosol Med Pulm Drug Deliv. 2015 Dec;28(6):486-97. doi: 10.1089/jamp.2015.1224. Epub 2015 Sep 15.
9
The Role of Inspiratory Pressures in Determining the Flow Rates Though Dry Powder Inhalers; A Review.吸气压力在决定通过干粉吸入器的流速方面的作用;综述
Curr Pharm Des. 2015;21(27):3974-83. doi: 10.2174/1381612821666150820105800.
10
Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study.探讨Diskus™吸入器的吸气峰流速与吸入量之间的关系以及基线肺量计参数:一项横断面研究。
Springerplus. 2014 Sep 2;3:496. doi: 10.1186/2193-1801-3-496. eCollection 2014.